Acquisition Expands National Patient Base and Strengthens Aptiva’s Leadership in Continuous Glucose Monitoring (CGM) Distribution

FORT LAUDERDALE, Fla., Oct. 7, 2025 /PRNewswire/ — Aptiva Medical, a Greenleaf Ventures portfolio company and one of the nation’s leading providers of continuous glucose monitoring (CGM) systems, today announced the completion of its acquisition of VeraMed Health.

This transaction significantly expands Aptiva Medical’s patient base, strengthens its referral and payor networks, and accelerates its rapid growth – further reinforcing its leadership in delivering advanced diabetes management solutions to patients across the country.

 

 

Greenleaf Ventures, the healthcare-focused private investment firm led by Timothy Stocksdale and David Wallace, has a long track record of building and scaling successful healthcare companies in the medical supply and pharmacy sectors, including Access Diabetic Supply, Arriva Medical, Comfort Medical, and AmerimedRx. Stocksdale and Wallace are also recognized for leading one of the industry’s most notable turnarounds – acquiring Liberty Medical, then the nation’s largest diabetic supply company, out of bankruptcy in 2014, restructuring it, and later selling it to Cardinal Health.

“This acquisition aligns perfectly with Aptiva Medical’s mission to build a leading, nationwide direct-to-patient CGM business,” said David Wallace, Co-Founder and Managing Partner of Greenleaf Ventures. “The VeraMed team has built an excellent foundation of patient care, and Aptiva Medical will ensure a seamless transition for every patient while continuing to raise the bar on service and efficiency.”

About Aptiva Medical

Aptiva Medical is a national leader in the home delivery of continuous glucose monitors (CGMs), diabetes testing supplies, and specialty transplant medications. The company provides end-to-end patient support – from prescription coordination and insurance billing to convenient home delivery – and partners with physicians, payors, and patients to improve adherence and outcomes. Aptiva Medical is headquartered in Fort Lauderdale, Florida.

About Greenleaf Ventures

Greenleaf Ventures is a private investment firm based in Fort Lauderdale, Florida, specializing in healthcare and medical supply companies. Founded by Timothy Stocksdale and David Wallace, Greenleaf has built, scaled, and exited multiple category-leading healthcare companies with a combined enterprise value exceeding $500 million.

Media Contact:

Aptiva Medical
6700 N. Andrews Avenue, Suite 700
Fort Lauderdale, FL 33309
(800) 252-9020
[email protected] | www.aptivamedical.com

SOURCE Greenleaf Ventures

Coloplast acquires Comfort Medical, a US direct-to-consumer nationwide dealer of catheters and ostomy supplies, for USD 160m. The acquisition is a continuation of Coloplast’s ambition to bring innovative products and services to the US market.

Coloplast has entered into a definitive agreement to acquire Comfort Medical, LLC (Comfort Medical) for a cash consideration of USD 160m equal to approx. DKK 1,120m. Comfort Medical is a privately owned, US direct-to-consumer Durable Medical Equipment (DME) nationwide dealer of catheters and ostomy supplies founded in Florida in 2010. The acquisition is a continuation of Coloplast’s ambition to bring innovative products and services to the US market.

“The acquisition of Comfort Medical fits very well into our overall consumer ambition for Coloplast in the US, securing continued access to innovative technology for end users. Comfort Medical has a strong patient acquisition model and an efficient and scalable setup in addition to a strong management team with a good cultural fit to Coloplast,” says Lars Rasmussen, Coloplast’s CEO.

Comfort Medical’s business model is based on capturing patients through Direct Response Advertisement and physician referrals. Comfort Medical provides patients with products from a number of different manufacturers including Coloplast. The company is expected to record sales of USD 38m or approx. DKK 270m for the full-year 2016.

“I am excited about the future prospects of our US business and view this acquisition as an additional building block in the implementation of our US strategy,” Lars Rasmussen says.

The transaction is expected to contribute to Coloplast’s long-term growth ambition and is expected to close in the first quarter of 2016/17. The acquisition will, if completed and approved by authorities, lead to a revised financial guidance for the financial year 2016/17:

• The organic revenue growth guidance of 7-8% is unchanged. The growth in DKK of 5-6% is expected to be 1-2%-points higher.
• The EBIT margin guidance of 33-34% in constant exchange rates and about 33% in DKK is unchanged.
• The long-term guidance of 7-9% organic growth p.a. and an EBIT margin expansion of 0.5%-1.0%-points p.a. is unchanged.

Read the release on the GlobeNewswire website here.

WALTHAM, Mass.–Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has acquired Arriva Medical, a leading provider of diabetes testing supplies to individuals in their homes. To acquire Arriva, Alere paid approximately $65 millioncash, subject to working capital and other closing adjustments, plus 806,452 restricted shares of Alere common stock. Based in Coral Springs, Florida, Arriva had revenues of approximately $21.5 million for the six months ended October 31, 2011.

Read the release on the PR Newswire website here.

Richmond, VA–Owens & Minor (NYSE-OMI) announced today it has acquired Access Diabetic Supply, LLC (Access), a Florida-based distributor of diabetic supplies. The acquisition complements Owens & Minor’s long-term strategy to expand its market and customer base in healthcare. Access primarily markets blood glucose monitoring devices, test strips and other ancillary products used by people with diabetes for self-testing, an important element in the day-to-day management of diabetes. The company also distributes products for certain other chronic disease categories. Access was a finalist for Ernst & Young’s 2003 Entrepreneur of the Year Award and was featured in Entrepreneur Magazine as the 25th fastest growing company in America in 2003.

“We are very excited about Access, which is a best-in-class company with a culture similar to Owens & Minor. We look forward to working with the talented Access teammates to build upon the already successful product supply and service business they have established,” said Craig R. Smith, president and chief operating officer of Owens & Minor. “This acquisition extends our core competency of medical products distribution into the home, and is consistent with our long-term strategy to expand our reach in the healthcare supply chain. This is a logical extension of our abilities into a rapidly growing market.”

Launched in 2000, Access, with 2004 revenues of approximately $32 million, ranks among the top 10 companies in the rapidly growing, $1 billion, direct-to-consumer diabetic supply sector. This market, driven by the increasing incidence of diabetes and other chronic health conditions, reflects the growing desire of patients to receive medical supplies directly through the mail. The number of Americans diagnosed with diabetes stands at approximately 13 million today, according to the American Diabetes Association, and that number is expected to reach 17 million diagnosed cases by 2009.

Today, Access distributes products to more than 50,000 customers across the United States and, as part of its successful business model, handles reimbursement tasks for its customers with Medicare and private insurers. Also, the company has a proven ability to capture new customers through its marketing techniques, and maintains its customer base with exceptional customer service. Growth in the sector is being fueled by customer preference for the convenience, confidentiality and ease of home delivery of medical supplies.

“We are very excited to become part of the Owens & Minor family,” said David A. Wallace, president of Access Diabetic Supply. “Owens & Minor shares our commitment to grow in the rapidly expanding, direct-to-consumer, diabetic supply sector. In addition, we look forward to tapping Owens & Minor’s experience and expertise in healthcare.”

As a result of the acquisition, the Access team of approximately 200 employees, along with the company’s executives, will join Owens & Minor. Access will operate as a separate entity within the corporate structure of Owens & Minor, Inc. subsidiaries.

Ewing Bemiss & Co. of Richmond, VA advised Owens & Minor in the transaction, while Brookwood Associates of Charlotte, NC advised Access.

Read the release on the sec.gov website here.